L-cysteine monohydrochloride (LCM) was added to the drinking water of groups of 50 male and 50 female F344/ DuCrj rats at levels of 0.5 and 0.25% for 108 weeks. There were no statistically significant differences between treated and control rats in the results of the urine and serum analyses or hematological determinations or in the incidences of tumors, apart from mammary, pituitary and peritoneal lesions. The mammary gland in the females and the pituitary adenoma in males showed some increase in tumor development over the concurrent controls but these values did not differ significantly from the reported spontaneous incidences in this strain. Mesotheliomas were found in 3 of 41 male rats treated with 0.5% LCM but this was again in line with historical control data. It was concluded that LCM does not induce any neoplasms when given orally to F344/DuCrj for 108 weeks.
Introduction
L-cysteine monohydrochloride (LCM) is one of the SH containing amino acids to relevant oxidation and reduction reactions, itself being important as a precursor for glutath ione. Since 1967, it has been applied as a food additive in Japan. At the present, it was mainly used by bread manufac tures as an additive to drinking water with vitamin C and in cosmetic articles. It has been reported that the acute toxicity of neocarcinostatin is reduced by pretreatment with Lcysteine monohydrochloride monohydrate in a dose-dependent fashion1-3. However, LCM can exert the toxicity in the kidney and liver4 and has proven positive in both the Ames and the chromosome mutagenecity tests5. Also, it may potentiate the nephrotoxicity of other compounds6.
There has been no report of any carcinogenicity of cysteine with long term treatment. The present study was therefore conducted to determine whether L-cysteine mono hydrochloride might cause histopathological lesions in rats when given in the drinking water for a two year period (108 weeks).
Materials and Methods

Preparation of test samples and animals
As the test material, L-cysteine Monohydrochloride 
Results
Survival rate, body weight, and LCM consumption data
The growth curves of both rats are shown in Fig. 1 . In both sexes, increase of body weights in the control group was slightly higher than in the treated groups.
Body weight and LCM consumption data are summarized in Table 1 . The body weights of male and female rats treated with LCM tended to be less than those of control rats.
Numbers of surviving rats at week 108 did not significantly differ between 
Laboratory investigations
Urine analysis data, hematological findings, and the results of serum laboratory tests are shown in Tables 2, 3 , 4-1 and 4-2. Values for A/G, ALP, GOT, and GPT in males, and A/G, GOT in females were signifiantly higher in the 0.5% group than in the control group. Values for TG and BUN in males, and BUN and Cr in females were also significantly elevated in the 0.5% group. There were no significant differences in urinalysis data and peripheral blood findings between the experimental groups and the control group.
Terminal body and organ weights, and tumor incidences Absolute and relative organ weights are shown in Table  5 and incidences of tumors in each organ are shown in Table  6 . In the LCM group, the mean absolute weights of the liver in males and of the heart, lung, and liver in females were significantly lower than those of the respective controls (Table 5) . For the males, tumors were found in 98% of the 0.5% LCM group, in 97% of the 0.25% group and in 100% of the controls, while the corresponding figures for the females were 48, 33, and 48%, respectively. These high proportions of tumor-bearing rats were due to the testis, thyroid, pituitary gland, pancreas, and uterus lesions. The tumor incidences of the peritoneum and pituitary gland in males, and mammary gland in females were slightly higher in treated rats than in the controls but not significantly. Uterine lesions were relatively common in all groups and mesotheliomas were seen in 3 of 41 0.5% group females (Table 6 ).
Non-malignant histological findings in the urinary system
Results for non-neoplastic histological changes in the kidneys are summarized in Table 7 . Necrosis of the renal papillae was seen in six of 38 females rats in the 0.5% group and 2 of 43 in the 0.25% group (Fig. 4) , in the 0.5% group, the incidence being significant (p<0.05). Hyperplasia of the kidney pelvis was also evident in single females of both treated groups along with calcification in 2 rats of the 0.5% group.
Discussion
In the present study, no difference in tumor incidences between treated and control rats were found but this was in line with the report of Maekawa et al.7 who described the spontaneous tumors in 99.7% of male and 84.5% of females F344 rats after 2 years. The incidences of tumors in female in our study was slightly higher than in previous reports but without any significance. Mesotheliomas were seen in 3 of 41 (7.3%) rats in the 0.5% male group as compared with around 3.5% in previous reports7-9. In general, the incidence of spontaneous tumors in animals depends on dietary and other environment factor, hormones, the genetic background factors, the microbiological status, and the age. In addition, incidences may also be influenced by the criteria used for histological identification of tumors.
Postmitochondrial supernatants from rat liver and kid ney homogenates were found to transform cysteine into a mutagen Salmonella typhimurium TA 100. Both cysteine and glutathione react positively in the Ames test12-14 and because L-cysteine is a substrate for the enzyme gamma glutamylcysteine synthetase, its administration can result in increased synthesis of glutathione1s. Modifying effects of captafol and L-cysteine on the development of glutathione S-trandferase placental form-positive (GST-P+) foci of the liver and expression of proliferating cell nuclear antigen (PCNA) in the kidney have been investigated in a medium term bioassay using D-galactosamine in rats3. Significant reduction by L-cysteine of areas of GST-P+ liver cell foci initiated by diethylnitrosamine, and the significant reduction of the PCNA-labelling indices of renal nodules in rats treated simultaneously with L-cysteine were found3.
In the present study, evidence of kidney toxicity in females was found in line with other literatures. Many cysteine compounds such as S-(1, 2-dichlorovinyl)-Lcysteine have nephrotoxic effect11. The severity of renal injury due to high inorganic mercury is significantly greater in rats administered L-cysteine15. However, when rats intraperitoneally injected with the chelating agents such as D or L-cysteine immediately after intravenous injection of gold sodium thiomalate (AuTM) demonstrated urinary type specific alteration of excretion various materials but no significant effect on the excretion or distribution of gold at 7 days after AuTM injections. Papillomas and necrosis of renal papillae in rats treated with glycine16 or phytic acid17 has been reported but no papillomas in rats treated with Lcysteine were seen in the present study.
In conclusion, the present study indicates that while Lcysteine may show some toxicity for the kidney of female rats it is neither carcinogenic nor does it promote carcinogenesis.
